Zobrazeno 1 - 10
of 57
pro vyhledávání: '"J. R. Bove"'
The in vitro exposure of 1 part of whole AGD blood to 19 parts of 5 % dextrose and one-quarter strength saline for 30, 60, 90 and 120 minutes before transfusion resulted in a 10 minutes in vivo chromium 51 RBC survival of 50, 20, 15 and 8% respective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdc16f9d226a12b8dddab7009ee475d4
https://doi.org/10.1159/000426290
https://doi.org/10.1159/000426290
Autor:
J. R. Bove
Publikováno v:
Transfusion Medicine Reviews. 20:169-171
Autor:
A Chernoff, J R Bove, D Ciavarella, L.K. Hoffstadter, D. Hines, N Postoway, D M Surgenor, P. Devine, J V Linden
Publikováno v:
Transfusion. 32:683-687
Responses to the 1990 American Association of Blood Banks (AABB) Institutional Membership Questionnaire were submitted by 2126 regional blood centers, hospital-based blood banks, and transfusion facilities. Data from 2117 of these facilities were con
Autor:
J. R. Bove
Publikováno v:
Transfusion. 30:63-67
In the past, testing by blood banks was intended primarily to ensure product quality or donor safety or to meet existing regulations. As a result of recent pressures, especially the AIDS epidemic, additional reasons to test have become evident. Altho
Autor:
Gregory J. Palermo, J. R. Bove
Publikováno v:
Transfusion. 21:757-758
Autor:
J. R. Bove
Publikováno v:
Transfusion. 33(7)
Autor:
J R, Bove
Publikováno v:
The Yale Journal of Biology and Medicine
Although the major diseases transmitted by transfusion today are AIDS and hepatitis, many others also are known. These include CMV, syphilis, Chagas disease, babesiosis, parvovirus B19, malaria, Epstein-Barr infection, and many others that have been
Publikováno v:
Transfusion. 27:203-206
A workshop sponsored by the Food and Drug Administration was held recently during which available data were reviewed concerning surrogate testing of blood donated for transfusion in order to reduce the risks of posttransfusion non-A, non-B hepatitis.